MADISON, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Wyeth announced today that it will present at the Credit Suisse First Boston Healthcare Conference on Wednesday, November 15, 2006 at 1:30 p.m. Eastern Time. Presenting for Wyeth will be Robert R. Ruffolo, Jr., Ph.D., Senior Vice President, Wyeth and President, Wyeth Research.
Wyeth’s presentation will be webcast live for investors at http://www.wyeth.com and available for replay following the conference.
Wyeth is one of the world’s largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products, and non-prescription medicines that improve the quality of life for people worldwide. The Company’s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare, and Fort Dodge Animal Health.
Wyeth
CONTACT: Media Contact - Douglas Petkus of Wyeth, +1-973-660-5218; orInvestor Contact - Justin Victoria of Wyeth, +1-973-660-5340
Web site: http://www.wyeth.com/
